Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry …

F Zhou, Y Wang, Y Liu, X Liu, L Gu… - European …, 2019 - Eur Respiratory Soc
Although broad knowledge of influenza viral pneumonia has been established, the
significance of non-influenza respiratory viruses in community-acquired pneumonia (CAP) …

Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients

R Carbonell, S Urgelés, M Salgado, A Rodríguez… - Journal of Infection, 2022 - Elsevier
ABSTRACT Background: Procalcitonin (PCT) and C-Reactive Protein (CRP) are useful
biomarkers to differentiate bacterial from viral or fungal infections, although the association …

Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia

DO Thomas-Rüddel, B Poidinger, M Kott, M Weiss… - Critical care, 2018 - Springer
Background This study aimed to evaluate the accuracy of procalcitonin (PCT) serum
concentrations to diagnose Gram-negative bacteremia and the association of PCT serum …

Community-acquired pneumonia

MB Rothberg - Annals of internal medicine, 2022 - acpjournals.org
Community-acquired pneumonia is an important cause of morbidity and mortality. It can be
caused by bacteria, viruses, or fungi and can be prevented through vaccination with …

Usefulness of procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) levels in the differential diagnosis of acute bacterial, viral, and mycoplasmal …

Y Li, L Min, X Zhang - BMC Pulmonary Medicine, 2021 - Springer
Background There is a lack of studies comparing PCT, CRP and WBC levels in the
differential diagnosis of acute bacterial, viral, and mycoplasmal respiratory tract infections. It …

[Translated article] Biological Biomarkers in Respiratory Diseases

F García-Río, B Alcázar-Navarrete… - Archivos de …, 2022 - Elsevier
In recent years, personalized or precision medicine has made effective inroads into the
management of diseases, including respiratory diseases. The route to implementing this …

Limited utility of procalcitonin in identifying community-associated bacterial infections in patients presenting with coronavirus disease 2019

M May, M Chang, D Dietz, S Shoucri… - Antimicrobial Agents …, 2021 - Am Soc Microbiol
The role of procalcitonin in identifying community-associated bacterial infections among
patients with coronavirus disease 2019 is not yet established. In 2,443 patients of whom 148 …

The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics

I Yunus, A Fasih, Y Wang - PloS one, 2018 - journals.plos.org
Objective The primary objective of this study was to determine the correlation between
procalcitonin values and illness severity by evaluating the degree of end organ dysfunction …

COVID-19: to be or not to be; that is the diagnostic question

JJ Coleman, K Manavi, EJ Marson… - Postgraduate …, 2020 - academic.oup.com
Since the first cases in December 2019, the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) has rapidly spread across the globe, resulting in the COVID-19 pandemic …

Severe respiratory viral infection induces procalcitonin in the absence of bacterial pneumonia

S Gautam, AJ Cohen, Y Stahl, PV Toro, GM Young… - Thorax, 2020 - thorax.bmj.com
Introduction Procalcitonin expression is thought to be stimulated by bacteria and suppressed
by viruses via interferon signalling. Consequently, during respiratory viral illness, clinicians …